Has a law designed to speed drug approvals resulted in excessive safety issues?
A new study finds that after the Prescription Drug User Fee Act was passed in 1992 – in which drug makers agreed to pay fees to help fund the FDA and the agency agreed to accelerate approvals – the number of safety warnings and product withdrawals was higher than before the law was passed.
